An association exists in primary human breast tumors between high epidermal growth factor receptor (EGFR) expression and a reduced number or even absence of estrogen receptors (ER). To determine whether an increase in EGFR expression might alter the estrogen responsiveness of an ERpositive human bre
Mammaglobin Gene Expression: A Superior Marker of Breast Cancer Cells in Peripheral Blood in Comparison to Epidermal-Growth-Factor Receptor and Cytokeratin-19
✍ Scribed by Grünewald, Kurt; Haun, Margot; Urbanek, Martina; Fiegl, Michael; Müller-Holzner, Elisabeth; Gunsilius, Eberhard; Dünser, Martina; Marth, Christian; Gastl, Günther
- Book ID
- 109886288
- Publisher
- Nature Publishing Group
- Year
- 2000
- Tongue
- English
- Weight
- 222 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0023-6837
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A number of studies suggest that an inverse correlation exists between the epidermal growth factor-receptor and the estrogen receptor expression in primary human breast carcinoma as well as in established human breast carcinoma cell lines. Recent studies suggest that the epidermal growth factor-rece
## Abstract The epidermal growth factor receptor (EGFR) exhibits an inverse correlation with estrogen receptor (ER) expression in the majority of breast cancers, predicting a poor response to endocrine therapy and poor survival rate. Inappropriate overexpression of EGFR in breast cancer is associat
## Abstract ## BACKGROUND The ISEL (Iressa Survival Evaluation in Lung Cancer) clinical trial evaluated the efficacy of gefitinib versus placebo in pretreated nonsmall‐cell lung cancer patients. Two different antibodies, scoring systems, and cutoff points of epidermal growth factor receptor (EGFR)